We are live on ! Find out more
APLT

Applied Therapeutics
APLT

Delisted

APLT was delisted on the 2nd of February, 2026.

Back to rankings

30 hedge funds and large institutions have $26.3M invested in Applied Therapeutics in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

567% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 3

131% more funds holding

Funds holding: 13 → 30 (+17)

45% more capital invested

Capital invested by funds: $18.1M → $26.3M (+$8.23M)

1.17% more ownership

Funds ownership: 12.88% → 14.05% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
30
Holders Change
+17
Holders Change %
+130.77%
% of All Funds
0.66%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
3
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
+$783K
2
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$673K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$330K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$228K
5
Northern Trust
Northern Trust
Illinois
+$152K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$283K
2
Goldman Sachs
Goldman Sachs
New York
-$203K
3
BlackRock
BlackRock
New York
-$57.9K
4
Alkeon Capital Management
Alkeon Capital Management
New York
-$7.18K
5
CCA
Catalyst Capital Advisors
New York
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
26
Ameritas Investment Partners
Nebraska
$2K +$1.6K +170 New
Bank of Montreal
27
Bank of Montreal
Ontario, Canada
$2K +$1.67K +177 New
Citigroup
28
Citigroup
New York
$1K +$840 +89 New
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$1K +$915 +97 New
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
$659 +$566 +60 New
Goldman Sachs
31
Goldman Sachs
New York
– -$203K -24,654 Closed
CCA
32
Catalyst Capital Advisors
New York
– -$7K -800 Closed
TRCT
33
Tower Research Capital (TRC)
New York
– -$4K -494 Closed
1
2

APLT Hedge Fund Activity: Q3 2019 in Review

30 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q3 2019, worth a combined $26.3M — up 45% from $18.1M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new APLT positions and 3 closed out — a net gain of 17 holders — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Acuta Capital Partners, opening a new position worth an estimated $783K. The largest seller was Millennium Management, cutting an estimated $283K.

  • 30 institutional investors held Applied Therapeutics (APLT) as of Q3 2019, up from 13 in Q2 2019.
  • Funds reported $26.3M of Applied Therapeutics stock for Q3 2019, up 45% quarter-over-quarter.
  • 20 funds opened new Applied Therapeutics positions in Q3 2019 and 3 closed out, a net change of +17 holders.
  • The largest Applied Therapeutics buyer in Q3 2019 was Acuta Capital Partners, an estimated $783K added.
  • The largest Applied Therapeutics seller in Q3 2019 was Millennium Management, an estimated $283K sold.

Based on aggregated 13F filings for Q3 2019.